Premium
NeuroSense Therapeutics Ltd (NRSN)
NASDAQ
Hot Features
Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases, these diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease and Parkinson's disease, among... NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases, these diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease and Parkinson's disease, among others. Its lead product candidate, PrimeC, is a novel extended-release, or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.01 | 0.892857142857 | 1.12 | 1.1998 | 1.05 | 129271 | 1.10286251 | CS |
| 4 | -0.04 | -3.4188034188 | 1.17 | 1.2399 | 1.0241 | 114582 | 1.11746395 | CS |
| 12 | 0.27 | 31.3953488372 | 0.86 | 1.42 | 0.81 | 247617 | 1.17212928 | CS |
| 26 | 0.01 | 0.892857142857 | 1.12 | 1.455 | 0.8 | 222695 | 1.16106386 | CS |
| 52 | -0.7 | -38.2513661202 | 1.83 | 2.25 | 0.512 | 241942 | 1.10598568 | CS |
| 156 | -0.34 | -23.1292517007 | 1.47 | 8.18 | 0.4 | 949328 | 3.41656154 | CS |
| 260 | -3.42 | -75.1648351648 | 4.55 | 8.18 | 0.4 | 927795 | 3.37156588 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
